293 related articles for article (PubMed ID: 20088679)
1. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).
Kadu PJ; Kushare SS; Thacker DD; Gattani SG
Pharm Dev Technol; 2011 Feb; 16(1):65-74. PubMed ID: 20088679
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin].
Shen HR; Li ZD; Zhong MK
Yao Xue Xue Bao; 2005 Nov; 40(11):982-7. PubMed ID: 16499080
[TBL] [Abstract][Full Text] [Related]
5. Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug.
Bandivadeka MM; Pancholi SS; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2012 Jul; 38(7):883-92. PubMed ID: 22087760
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium.
Yin YM; Cui FD; Kim JS; Choi MK; Choi BC; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2009 Jan; 16(1):30-6. PubMed ID: 19555306
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
Kim JS; Kim MS; Park HJ; Jin SJ; Lee S; Hwang SJ
Int J Pharm; 2008 Jul; 359(1-2):211-9. PubMed ID: 18501538
[TBL] [Abstract][Full Text] [Related]
8. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.
Balakumar K; Raghavan CV; selvan NT; prasad RH; Abdu S
Colloids Surf B Biointerfaces; 2013 Dec; 112():337-43. PubMed ID: 24012665
[TBL] [Abstract][Full Text] [Related]
9. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
Ali KA; Mukherjee B; Bandyopadhyay AK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
[TBL] [Abstract][Full Text] [Related]
10. Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design.
Nanda Kishore R; Yalavarthi PR; Vadlamudi HC; Vandana KR; Rasheed A; Sushma M
Drug Dev Ind Pharm; 2015; 41(7):1213-22. PubMed ID: 25019500
[TBL] [Abstract][Full Text] [Related]
11. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
13. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study.
Bandivadekar M; Pancholi S; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2013 May; 39(5):696-703. PubMed ID: 22616839
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
Anwar M; Warsi MH; Mallick N; Akhter S; Gahoi S; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
Eur J Pharm Sci; 2011 Oct; 44(3):241-9. PubMed ID: 21864678
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of self-nanoemulsifying drug delivery systems (SNEDDS) of atorvastatin calcium.
Mantri SK; Pashikanti S; Murthy KV
Curr Drug Deliv; 2012 Mar; 9(2):182-96. PubMed ID: 22283646
[TBL] [Abstract][Full Text] [Related]
16. Facile preparation of monodisperse pharmaceutical colloidal spheres of atorvastatin calcium via self-assembly.
Zhang HX; Zhao H; Wang JX; Chen JF; Lu YF; Yun J
Small; 2009 Aug; 5(16):1846-9. PubMed ID: 19415652
[No Abstract] [Full Text] [Related]
17. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
[TBL] [Abstract][Full Text] [Related]
18. HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.
Shen HR; Li ZD; Zhong MK
Pharmazie; 2006 Jan; 61(1):18-20. PubMed ID: 16454200
[TBL] [Abstract][Full Text] [Related]
19. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and bioequivalence testing of atorvastatin formulations in healthy male volunteers.
Mendoza L; Hajdúch M; Plausinaitis R; Platílová V; Emritte N; Svoboda M
Pharmazie; 2006 Sep; 61(9):805-6. PubMed ID: 17020163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
